SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 399,649.15 |
| Enterprise Value ($M) | 412,178.15 |
| Book Value ($M) | 70,158.00 |
| Book Value / Share | 29.11 |
| Price / Book | 5.70 |
| NCAV ($M) | -52,721.00 |
| NCAV / Share | -21.88 |
| Price / NCAV | -7.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.13 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.86 |
| Current Ratio | 1.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 55,893.00 |
| Assets | 180,104.00 |
| Liabilities | 108,614.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 88,821.00 |
| Operating Income | 21,249.00 |
| Net Income | 14,066.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 24,266.00 |
| Cash from Investing | -18,599.00 |
| Cash from Financing | -3,132.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,443,090 | 15,856,037 | 21.71 | |
| 1,258,968 | 7,789,593 | 16.16 | |
| 957,577 | 4,208,533 | 22.75 | |
| 1,160,084 | 4,777,129 | 24.28 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELAN – Elanco Animal Health Incorporated | ENZ – Enzo Biochem, Inc. |
| HYAC – Haymaker Acquisition Corp. 4 | LLY – Eli Lilly and Company |
| MRK – Merck & Co., Inc. | |